Capitolis Liquid Global Markets’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.5M Buy
571,730
+347,900
+155% +$40.7M 0.32% 69
2026
Q1
$26.9M Sell
223,830
-236,570
-51% -$27.3M 0.17% 108
2025
Q4
$48.5M Buy
460,400
+206,700
+81% +$19.4M 0.29% 76
2025
Q3
$21.3M Sell
253,700
-415,000
-62% -$34.2M 0.17% 91
2025
Q2
$52.9M Buy
668,700
+65,000
+11% +$5.17M 0.39% 52
2025
Q1
$54.2M Hold
603,700
0.48% 46
2024
Q4
$60.1M Hold
603,700
0.58% 41
2024
Q3
$68.6M Buy
603,700
+302,000
+100% +$35.9M 0.73% 34
2024
Q2
$37.4M Buy
301,700
+215,000
+248% +$27.7M 0.46% 48
2024
Q1
$11.4M Buy
86,700
+13,400
+18% +$1.65M 0.18% 70
2023
Q4
$7.99M Buy
+73,300
New +$7.61M 0.33% 49

Other funds holding MRK

Capitolis Liquid Global Markets's MRK Position: Q2 2026 in Review

Capitolis Liquid Global Markets increased its Merck (MRK) stake by 155% in Q2 2026, buying an estimated $40.7M and bringing the position to 571,730 shares worth $73.5M. The position accounts for 0.32% of the portfolio, ranked #69.

Capitolis Liquid Global Markets first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capitolis Liquid Global Markets held 571,730 shares of Merck worth $73.5M as of Q2 2026.
  • Capitolis Liquid Global Markets bought 347,900 Merck shares in Q2 2026, an estimated $40.7M.
  • Merck made up 0.32% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #69 holding.
  • Capitolis Liquid Global Markets first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.